Navigation Links
Ocular Therapeutix, Inc. Receives IDE Approval to Conduct a Pivotal Clinical Trial for ReSure™ Sealant

BEDFORD, Mass., Feb. 6, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today that it has received IDE approval from the U.S. Food and Drug Administration to conduct a pivotal clinical trial with ReSure Sealant, a proprietary synthetic hydrogel polymer for ophthalmic use over clear corneal incisions.

The randomized, parallel-arm clinical trial will test the safety and efficacy of the device, relative to sutured closure, for prevention of postoperative fluid egress on clear corneal incisions following cataract or intraocular lens placement surgery.  The trial will be conducted at up to 24 sites throughout the United States. 

Cataract surgery is the most commonly performed surgery in the United States, with well over 3 million procedures conducted annually.  Clear corneal wound leaks are widely thought to be a contributing factor to many post-surgical complications.  Presently, ophthalmologists use stromal hydration to close these wounds, however, recent literature has shown that this technique may not be enough to create a watertight seal, and therefore more protection is necessary.  "In a time where wound integrity is under scrutiny, this product fills a void where our only option for closure of vulnerable incisions was sutures," stated Steven Dell, Medical Director of Dell Laser Consultants.  "ReSure Sealant could be a huge step forward for protecting our patients' eyes post-operatively."

"We are very excited to have developed a robust study with FDA's input to definitively demonstrate the utility of the ReSure Sealant compared to older methods of incision closure and management in clear corneal cataract surgery," stated Amar Sawhney, President and CEO of Ocular Therapeutix, Inc.  "We look forward to completing the trial and making the ReSure Sealant available to US physicians by next year."   

About Ocular Therapeutix, Inc.:

Founded in November 2006, Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology. Ocular Therapeutix is also using its hydrogel technology for development of sustained ocular drug delivery vehicles, such as absorbable punctum plugs to deliver moxifloxacin for the treatment of bacterial conjunctivitis, and travoprost for the treatment of glaucoma.

About ReSure Sealant:

ReSure Sealant is a synthetic hydrogel polymer which is applied as a liquid and gels in situ on the ocular surface, creating a soft and lubricious surface barrier.  The Sealant is designed to stay on the incision in the immediate post-operative period when wounds are most vulnerable, after which it gently sloughs off in the patient's tears. 


SOURCE Ocular Therapeutix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AMD Alliance, Representing AMD Patient Organizations Globally, Encourages Health Care Providers to Stop Using Avastin for Off-Label Ocular Use
2. NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens Candidates
3. Oxford BioMedica Announces Ocular Programme Update
4. Reportlinker Adds Global Intraocular Lenses Industry
5. Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
6. Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
7. Sylentis Completes Phase I Trial with SYL040012 to Treat Elevated Intraocular Pressure and Glaucoma
8. Tekia Enters Into Distribution Agreement With Fritz Ruck/T-MED, Germany to Market Its Accommodative Intraocular Lens to Treat Presbyopia
9. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
10. Quark Announces Dosing of the First Patient in Phase I Clinical Trial of its Ocular Neuroprotective Agent, QPI-1007
11. Ocular Therapeutix, Inc. Appoints Two New Board Members
Post Your Comments:
(Date:11/24/2015)... November 25, 2015 The hope ... repeated failure of IVF cycles. After failure of over ... and had lost all hopes that she would be able to conceive ever. ... child conceived after failure of over 15 IVF cycles. ... before they decided to take one last attempt with Gaudium IVF ...
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
(Date:11/25/2015)... ... November 25, 2015 , ... Many people know of the ... gain, cold hands, and dry skin. But many people who find their cholesterol levels ... regimen instead of their thyroid, especially if they don’t have any of the other ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion Bootie , ... early celebration of the early holiday shopping season. Starting Wednesday November 25th, Bunion ... ea). Black Friday promotional pricing is in addition to any automatic discounts applied ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
Breaking Medicine News(10 mins):